The Relationship between Advanced Oxidation Protein Products, Vascular Calcifications and Arterial Stiffness in Predialysis Chronic Kidney Disease Patients

Ion-Vlad Vinereanu,Ileana Peride,Andrei Niculae,Andreea Taisia Tiron,Andra Caragheorgheopol,Dana Manda,Ionel Alexandru Checherita
DOI: https://doi.org/10.3390/medicina57050452
2021-05-06
Medicina
Abstract:Background and Objectives: Cardiovascular morbidity and mortality are increased in patients with chronic kidney disease (CKD). It is likely that the accumulation of uremic toxins resulting in increased oxidative stress (OS) is a major contributing factor, but no clear link has been identified. The purpose of this research is to establish if advanced oxidation protein product (AOPP) levels in the serum of predialysis patients are a contributing factor to vascular calcification and increased arterial stiffness. Materials and Methods: After obtaining the informed consent, 46 predialysis patients (CKD stages G3–G5) were included in the study. In order to identify vascular calcifications, hand and pelvic radiographs were performed. Valvular calcifications were identified using cardiac ultrasound. AOPP were measured using a commercially available ELISA kit. The relationships between serum AOPP values and biochemical parameters relevant in the evaluation of CKD patients were analyzed. In addition to identifying the differences in AOPP levels between patients with/without vascular or valvular calcifications, the research focused on describing the relationship between OS and arterial stiffness assessed by oscillometric pulse-wave velocity (PWV) measurement. Results: No significant relationship between serum AOPP and vascular or valvular calcifications was highlighted, but significant correlations of AOPP with C-reactive protein (p = 0.025), HDL-cholesterol levels (p = 0.04), HbA1c (p = 0.05) and PWV values (p = 0.02) were identified. Conclusions: The usefulness of (OS) measurement in clinical practice remains debatable; however, the relationship between AOPP and arterial stiffness could be valuable in improving cardiovascular risk assessment of patients with CKD.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between the levels of advanced oxidation protein products (AOPP) in the serum of patients with chronic kidney disease (CKD) and vascular calcification and arteriosclerosis. Specifically, the study aims to: 1. **Evaluate whether AOPP levels are a factor contributing to vascular calcification and arteriosclerosis in CKD patients**: By analyzing the AOPP levels of 46 non - dialysis CKD patients, the researchers hope to determine whether AOPP is related to these pathological processes. 2. **Analyze the relationship between AOPP and other cardiovascular assessment indicators**: In addition to vascular calcification and arteriosclerosis, the study also focuses on the relationship between AOPP and inflammatory markers (such as C - reactive protein), blood lipid levels (such as HDL cholesterol), and blood - glucose control indicators (such as HbA1c). 3. **Explore the potential value of AOPP in clinical practice**: Through these analyses, the researchers hope to evaluate the potential value of AOPP as a cardiovascular risk - assessment tool, especially in CKD patients. ### Main findings: - **No significant correlation between AOPP and vascular or valvular calcification**: The study did not find a significant association between AOPP levels and vascular or valvular calcification. - **Significant correlation between AOPP and arteriosclerosis**: AOPP levels are positively correlated with pulse - wave velocity (PWV), especially after adjusting for serum creatinine levels, this correlation is more obvious. - **Correlation between AOPP and other metabolic parameters**: There are significant correlations between AOPP and C - reactive protein, HDL cholesterol, HbA1c, as well as the total cholesterol/HDL ratio and the LDL/HDL ratio. ### Conclusion: Although AOPP has been proven to be related to multiple pathological processes in laboratory studies, in clinical practice, the direct relationship between AOPP and vascular calcification is still unclear. However, the relationship between AOPP and arteriosclerosis may have certain value for improving cardiovascular risk assessment in CKD patients. Further research is needed to explore the role of AOPP in patients at different CKD stages and its potential application in predicting cardiovascular events.